Endothelin B receptor contribution to peripheral microvascular function in women with polycystic ovary syndrome

Journal of Physiology

Volumn 589, Issue 19, 2011, Pages 4671-4679

  Wenner, Megan M ^a,b   Taylor, Hugh S ^b   Stachenfeld, Nina S ^a,b  

^a JOHN B PIERCE LABORATORY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEATING; HUMAN; MICROCIRCULATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; SKIN BLOOD FLOW; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION; WARMING;

ADULT; CARDIOVASCULAR DISEASES; ENDOTHELIN-1; ENDOTHELIN-2; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MICROCIRCULATION; MICROVESSELS; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PIPERIDINES; POLYCYSTIC OVARY SYNDROME; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; REGIONAL BLOOD FLOW; SKIN; VASOCONSTRICTION; VASODILATION; YOUNG ADULT;

EID: 80053388079     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.216218     Document Type: Article

References (33)

1. Abbott DH, Dumesic DA & Franks S (2002). Developmental origin of polycystic ovary syndrome. J Endocrinol 174, 1-5.
2. Ariai H, Seiji H, Aramori I, Nakanishi O & Nakanishi S (1990). Cloning and expression of a cDNA encoding endothelin receptor. Nature 348, 730-732.
3. Cracowski JL, Minson CT, Salvat-Melis M & Halliwill JR (2006). Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol Sci 27, 503-508.
4. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J & Dzau VJ (1990). Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 86, 228-234.
5. Ergul A, Shoemaker K, Puett D & Tackett RL (1998). Gender differences in the expression of endothelin receptors in human saphenous veins in vitro. J Pharmacol Exp Ther 285, 511-517.
6. Gambineri A, Pelusi C, Vicennati V, Pagotto U & Pasquali R (2002). Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 26, 883-896.
7. Haynes MP, Strachan FE & Webb DJ (1995). Coronary heart disease/myocardial infarction/systemic vascular responses: endothelin ET sub A and ET sub B receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 92, 357-363.
8. Haynes WG (1995). Endothelins as regulators of vascular tone in man. Clin Sci (Colch) 88, 509-517.
9. Holowatz LA (2008). Human cutaneous microvascular ageing: potential insights into underlying physiological mechanisms of endothelial function and dysfunction. J Physiol 586, 3301.
10. Holowatz LA, Thompson-Torgerson CS & Kenney WL (2008). The human cutaneous circulation as a model of generalized microvascular function. J Appl Physiol 105, 370-372.
11. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Furokoda T, Fukami T, Ozaki S, Nagase T, Nishikibe M & Yano M (1994). Biochemical and pharmacological profile of a potent and selective endothelin β-receptor antagonist, BQ-788. Proc Natl Acad Sci U S A 91, 4892-4896.
12. Kellogg DL Jr, Zhao JL & Wu Y (2008). Endothelial nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo. Am J Physiol Heart Circ Physiol 295, H123-H129.
13. Kellogg DL, Liu Y & Pergola PE (2001). Gender differences in the endothelin-B receptor contribution to basal cutaneous vascular tone in humans. J Appl Physiol 91, 2407-2411.
14. Kim KH, Moriarty K & Bender JR (2008). Vascular cell signaling by membrane estrogen receptors. Steroids 73, 864-869.
15. Kimura N, Mizokami A, Oonuma T, Sasano H & Nagura H (1993). Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. J Histochem Cytochem 41, 671-678.
16. Kravariti M, Naka KK, Kalantaridou SN, Kazakos N, Katsouras CS, Makrigiannakis A, Paraskevaidis EA, Chrousos GP, Tsatsoulis A & Michalis LK (2005). Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 90, 5088-5095.
17. Kruger A, Stewart J, Sahityani R, O'Riordan E, Thompson C, Adler S, Garrick R, Vallance P & Goligorsky MS (2006). Laser Doppler flowmetry detection of endothelial dysfunction in end-stage renal disease patients: correlation with cardiovascular risk. Kidney Int 70, 157-164.
18. [1-31], a new vasoconstrictor peptide. British J Clin Pharmacol 57, 720-725.
19. Levin ER (2001). Cell localization, physiology, and nongenomic actions of estrogen receptors. J Appl Physiol 91, 1860-1867.
20. Lin HY, Kaji EH, Winkel GK, Ives HE & Lodish HF (1991). Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor. Proc Natl Acad Sci U S A 88 3185-3189.
21. Mather JK, Veram S, Corenblum B & Anderson T (2000). Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome. J Clin Endocrinol Metab 85, 1851-1856.
22. McCrohon JA, Jessup W, Handelsman DJ & Celermajer DS (1999). Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation 99, 2317-2322.
23. Minson CT (2010). Thermal provocation to evaluate microvascular reactivity in human skin. J Appl Physiol 109, 1239-1246.
24. Minson CT, Berry LT & Joyner MJ (2001). Nitric oxide and neurally mediated regulation of skin blood flow during local heating. J Appl Physiol 91, 1619-1626.
25. Orio F, Palomba S, Cascella R, De Simone B, Di Biase S, Russo T, Laballa D, Zullo F, Lomardi G & Colao A (2004). Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab 89, 4588-4593.
26. Padmanabhan V (2009). Polycystic ovary syndrome -"A riddle wrapped in a mystery inside an enigma". J Clin Endocrinol Metab 94, 1883-1885.
27. Polderman KH, Stehouwer CD, van Kamp GJ, Dekker GA, Verheught FWA & Gooren LJG (1993). Influence of sex hormones on plasma endothelin levels. Ann Intern Med 118, 429-432.
28. Polderman KH, Stehouwer CD, van Kamp GJ, Schalkwijk CG & Gooren LJ (2000). Modulation of plasma endothelin levels by the menstrual cycle. Metabolism 49, 648-650.
29. Raja-Khan N, Shuja SA, Kunselman AR, Hogeman CS, Demers LM, Gnatuk CL & Legro RS (2010). Brachial artery conductance during reactive hyperemia is increased in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 155, 49-53.
30. Sokolnicki LA, Roberts SK, Wilkins BW, Basu A & Charkoudian N (2007). Contribution of nitric oxide to cutaneous microvascular dilation in individuals with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 292, E314-318.
31. Stachenfeld NS, Yeckel CW & Taylor HS (2010). Greater exercise sweating in obese women with Polycystic Ovary Syndrome compared with obese controls. Med Sci Sports Exerc 42, 1660-1668.
32. Trivax B & Azziz R (2007). Diagnosis of polycystic ovary syndrome. Clin Obstet Gynecol 50, 168-177.
33. Wenner MM, Taylor HS & Stachenfeld NS (2011). Progesterone enhances adrenergic control of skin blood flow in women with high but not low orthostatic tolerance. J Physiol 589, 975-986.